American Water (AWK) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $84 price target. The company is leveraged to benefit from increased infrastructure spending and privatization, analysts said.
Commercial Metals (CMC) was upgraded to buy at Jefferies. $20 price target. The company is leveraged to increased infrastructure spending, Jefferies said.
F5 Networks (FFIV) was upgraded to neutral from reduce at Nomura. $130 price target. Product refresh is progressing better than expected, Nomura said.
Globus (GMED) was downgraded to market perform from outperform at JMP Securities. Sales force challenges will likely remain for another two quarters, JMP said.
Globus was downgraded to perform at Oppenheimer. $23 price target. Sales force issues will continue to linger, Oppenheimer said.
Globus was downgraded to market perform at William Blair. The company cut guidance, given lower organic growth, Blair said.
GoPro (GPRO) was downgraded to neutral from outperform at Wedbush. $9 price target. The company's latest misstep is a recall of the Karma product, Wedbush said.
Kansas City Southern (KSU) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $94 price target. Trump victory places Mexico growth strategy at risk, analysts said.
Lear (LEA) was downgraded to underperform from neutral at Bank of America/Merrill Lynch. $115 price target. The industry is hurt by risk of trade changes, especially NAFTA, analysts said.
Lockheed Martin (LMT) was upgraded to buy from hold at Deutsche Bank. The stock has pulled back, but the company is leveraged to higher defense spending, Deutsche said.
Constellation Brands (STZ) was downgraded to underperform from buy at Bank of America/Merrill Lynch. $150 price target. Trump victory creates uncertainty for Mexican beer assets, analysts said.
Sysco (SYY) was upgraded to equal-weight at Barclays. $53 price target. The valuation is more attractive, as higher revenue is driving margin expansion, Barclays said.
Tenet Healthcare (THC) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $25 price target. Desire to repeal healthcare reform is a negative for the hospital sector, analysts said.
Voya (VOYA) was downgraded to outperform from top pick at RBC Capital. The valuation is less attractive, based on a $37 price target, RBC said.
U.S. Steel (X) was upgraded to buy at Jefferies. $26 price target. Steel price momentum should build heading into 2017, aided by a Trump .victory, Jefferies said.